Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Three High Growth Stocks With Significant Insider Ownership

In This Article:

In the wake of a "red sweep" in the U.S. elections, global markets have been buoyed by expectations of faster earnings growth and lower corporate taxes, with major indices like the S&P 500 and Nasdaq Composite reaching record highs. Amidst this optimistic backdrop, identifying growth companies with significant insider ownership can provide valuable insights into potential investment opportunities, as insider confidence often aligns with strong company fundamentals and long-term growth prospects.

Top 10 Growth Companies With High Insider Ownership

Name

Insider Ownership

Earnings Growth

People & Technology (KOSDAQ:A137400)

16.4%

36.6%

Medley (TSE:4480)

34%

30.4%

Pharma Mar (BME:PHM)

11.8%

56.4%

Findi (ASX:FND)

34.8%

64.8%

Credo Technology Group Holding (NasdaqGS:CRDO)

13.9%

95%

Alkami Technology (NasdaqGS:ALKT)

11.2%

98.6%

Adveritas (ASX:AV1)

21.2%

144.2%

Plenti Group (ASX:PLT)

12.8%

107.6%

EHang Holdings (NasdaqGM:EH)

32.8%

81.4%

Brightstar Resources (ASX:BTR)

16.2%

84.6%

Click here to see the full list of 1528 stocks from our Fast Growing Companies With High Insider Ownership screener.

Below we spotlight a couple of our favorites from our exclusive screener.

MBC Group

Simply Wall St Growth Rating: ★★★★★☆

Overview: MBC Group is a media company operating in the United Arab Emirates, Saudi Arabia, Egypt, Iraq, North Africa, and internationally with a market cap of SAR15.66 billion.

Operations: Revenue segments for the company include Broadcasting at SAR3.25 billion, Digital Media at SAR1.75 billion, and Content Production at SAR2.10 billion.

Insider Ownership: 36%

Earnings Growth Forecast: 33.9% p.a.

MBC Group's earnings are forecast to grow significantly, outpacing the Saudi Arabian market. Despite volatile share prices recently, its revenue is expected to increase over 20% annually. A recent agreement for the Public Investment Fund to acquire a 54% stake for SAR 7.5 billion highlights strong insider ownership dynamics. However, large one-off items have impacted financial results, and future return on equity is projected to be relatively low at 11%.

SASE:4072 Earnings and Revenue Growth as at Nov 2024
SASE:4072 Earnings and Revenue Growth as at Nov 2024

Shanghai INT Medical Instruments

Simply Wall St Growth Rating: ★★★★★☆

Overview: Shanghai INT Medical Instruments Co., Ltd. (SEHK:1501) operates in the medical instruments industry and has a market cap of HK$4.93 billion.

Operations: The company's revenue from the Cardiovascular Interventional Business segment is CN¥718.71 million.